SNX30 divergent transcript (SNX30-DT)

SNX30 divergent transcript (SNX30-DT) is a human long non-coding RNA (lncRNA) encoded at chromosome 9 (chr9:112743028-112750622, hg38)[5]. This transcript is transcribed antisense or in a divergent orientation from the SNX30 gene, which codes for Sorting Nexin 30 (a protein involved in endosomal sorting and trafficking)[3][6]. Divergent non-coding RNAs like SNX30-DT often regulate their adjacent protein-coding genes in cis, suggesting that SNX30-DT may modulate the expression of SNX30 and, by extension, influence endosomal function or related pathways[1][2][7]. SNX30-DT is not a classical therapeutic target; it does not encode a functional protein and is not directly targeted by drugs. Its biological and pathological functions are largely inferred by analogy to other divergent lncRNAs, which are known to modulate gene expression, cell differentiation, and have roles in development or cancer, as suggested in literature analyzing divergent transcripts at large[2][7]. SNX30-DT is noted in the context of breast cancer research, suggesting potential disease relevance[1]. Divergent transcription (bidirectional promoters producing ncRNAs and mRNAs) is linked to transcription regulation, chromatin state, developmental gene expression, and sometimes cancer[2][7]. There is currently no evidence in scientific literature for any direct drug interactions, biomarker applications, or safety concerns related to SNX30-DT.

Other names

SNX30-DTSNX30 divergent transcript